Moreover, there is increasing evidence that adrenomedullin and its receptors are associated with the development and spread of tumours, resulting in the proposal of blockades for adrenomedullin and its receptors as potential treatments in multiple cancers [7,9,14]. The gene discussed is ADM; the disease is neoplasm.